Our mission is to make heart bypass surgery safer, less painful, more accessible, and less expensive by eliminating the need for vessel harvesting.
We’re working to improve bypass surgery by creating a revolutionary functional artificial blood vessel that will enhance the quality of life and speed the recovery of millions of patients.
Hearts are complex organs that are difficult to replicate and repair. Artificial grafts and vessels need to be biocompatible, flexible, and strong — but traditional methods often fail, clog, and create complications for the patient.
In order to perform a heart bypass, surgeons must harvest blood vessels from different areas of the body. It’s a slow, painful, and grueling process that leads to longer surgeries and recovery times for patients. Our technology eliminates the need for this step, which in turn eliminates these negative side effects. We improve a patient’s experience and recovery while reducing costs for the healthcare system.
We want to improve patient lives by changing how cardiac bypass surgery is performed. We’re eliminating a massive impediment in the procedure while reducing recovery time and complications for patients.
Cardiac bypass surgery is a complex, personal, and challenging process that has a deep impact on patients and their families. Through our innovation, we aim to create a new, valuable option for patients that minimizes their stress — both emotionally and physically.
We have created a small-diameter graft that is strong, flexible, biocompatible, and ready for human trials. By eliminating the need for saphenous vein harvesting, our MAVERICS artificial graft reduces pain, risks, costs, and recovery time.
We believe cardiac bypass surgery should be available to all patients. Our graft can be used regardless of the condition of a patient’s veins; people with severe diabetes, varicose veins, and amputations will be able to undergo the bypass procedure with our graft system. The MAVERICS graft also reduces wait time for surgery, cuts down on days spent in ICU recovery, and reduces wound-related post-operative care and readmissions.
Stay informed on how Medical 21 can improve your life by subscribing below.
Medical 21 is open to investors through Regulation A+ fundraising, which allows accredited investors and the general public alike to participate.
Learn how you can join us in reshaping the future of cardiac bypass surgery.